Published in AIDS Weekly, June 2nd, 2003
The results of this study indicated a sensitivity of 100% to all specimens collected from the 100 HIV-infected participants recruited from the Immunology Clinic of The Miriam Hospital. The Reveal Rapid HIV-1 Antibody Test has very recently received a premarket approval from the U.S. Food and Drug Administration.
"The Reveal Rapid HIV-1 Antibody Test is sensitive and easy to perform," said Dr. Michele Lally, the lead investigator at Brown...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.